More on QNTM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.87 |
|
|||
| Open | $2.87 | ||||
| 52 Wk High | $2.00 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $2.87 | ||||
| Day Low | $2.87 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 470 | ||||
- Form SCHEDULE 13G Quantum Biopharma Ltd. Filed by: AdvisorShares Trust
- NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis
- Quantum BioPharma MS drug candidate moves toward phase 2 trials
- Quantum BioPharma MS drug candidate nears phase 2 trials
- Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
- Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
- The Quest to Repair What Multiple Sclerosis Takes Away
- Quantum BioPharma's MS drug candidate nears phase 2 trials
- Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
- Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
Entities mentioned with QNTM
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- CIBC | View Related Stories »
- FDA | View Related Stories »
- IPO | View Related Stories »
- Bitcoin | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
